Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicentre, Double Blind, Prospective, Randomised, Controlled, Multiple Treatment Study Assessing Efficacy And Safety Of DYSPORT® Used In The Treatment Of Upper Limb Spasticity In Children

NCT02106351 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02106351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02106351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Controlled, Multiple Treatment Study Assessing Efficacy And Safety Of DYSPORT® Used In The Treatment Of Upper Limb Spasticity In Children
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2014
Completion date
September 4, 2018
Enrollment
212 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

upper limb spasticity (altered skeletal muscle performance) in children